
Biomy, Inc. is a Japanese company specializing in precision medicine through AI-based spatial analysis technology. Founded in 2019, it focuses on understanding complex cancer conditions and providing tailored treatment suggestions. Their flagship product, DeepPathFinder™, is designed for research use, enabling insights into tumor microenvironments and drug efficacy. With a strong team of experts in AI and medical research, Biomy aims to support the pharmaceutical sector and clinical labs with innovative solutions.

Biomy, Inc. is a Japanese company specializing in precision medicine through AI-based spatial analysis technology. Founded in 2019, it focuses on understanding complex cancer conditions and providing tailored treatment suggestions. Their flagship product, DeepPathFinder™, is designed for research use, enabling insights into tumor microenvironments and drug efficacy. With a strong team of experts in AI and medical research, Biomy aims to support the pharmaceutical sector and clinical labs with innovative solutions.